Answer
Soliris (eculizumab) is contraindicated in patients with hypersensitivity to eculizumab, murine proteins or any excipient listed in section 6.1.
Sources for this answer
- Soliris 300 mg concentrate for solution for infusionAlexion Pharma UK Ltd · emc · SmPC §4.3 Contraindications · Version 29Document updated
Sources checked